Black Rock Inc. Opgen Inc Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.32 - $0.79 $30,722 - $75,847	-96,009 Reduced 23.03%	320,804 $175,000
Q1 2022 May 12, 2022	SELL	$0.72 - $1.11 $3,350 - $5,164	-4,653 Reduced 1.1%	416,813 $313,000
Q4 2021 Feb 10, 2022	BUY	$1.0 - $2.94 $323,388 - $950,760	323,388 Added 329.73%	421,466 $422,000
Q3 2021 Nov 09, 2021	SELL	$2.18 - $3.58 $22,000 - $36,129	-10,092 Reduced 9.33%	98,078 $282,000
Q2 2021 Aug 11, 2021	BUY	$1.95 - $2.8 $210,931 - $302,876	108,170 New	108,170 $246,000

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $38.7M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.